Characterization of uterine leiomyomas by whole-genome sequencing

New England Journal of Medicine

Volumn 369, Issue 1, 2013, Pages 43-53

  Mehine, Miika ^a   Kaasinen, Eevi ^a   Mäkinen, Netta ^a   Katainen, Riku ^a   Kämpjärvi, Kati ^a   Pitkänen, Esa ^a   Heinonen, Hanna Riikka ^a   Bützow, Ralf ^a   Kilpivaara, Outi ^a   Kuosmanen, Anna ^a   Ristolainen, Heikki ^a   Gentile, Massimiliano ^b   Sjöberg, Jari ^a   Vahteristo, Pia ^a   Aaltonen, Lauri A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b CSC Scientific Computing Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; COL4A5 GENE; COL4A6 GENE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE SEQUENCE; GENE TRANSLOCATION; HMGA2 GENE; HUMAN; HUMAN TISSUE; MYOMETRIUM; PRIORITY JOURNAL; RAD51B GENE; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; UTERUS MYOMA; WHOLE GENOME SEQUENCING;

EID: 84879771630     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1302736     Document Type: Article

References (43)

1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-8. (Pubitemid 20316570)
2. Stewart EA. Uterine fibroids. Lancet 2001;357:293-8. (Pubitemid 32120866)
3. Jacoby VL, Autry A, Jacobson G, Domush R, Nakagawa S, Jacoby A. Nationwide use of laparoscopic hysterectomy compared with abdominal and vaginal approaches. Obstet Gynecol 2009;114:1041-8.
4. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003;111:1037-54. (Pubitemid 36826884)
5. Leibsohn S, d'Ablaing G, Mishell DR Jr, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 1990;162:968-76. (Pubitemid 20155415)
6. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma. Cancer Genet Cytogenet 2005;158:1-26. (Pubitemid 40354320)
7. Ligon AH, Morton CC. Genetics of uterine leiomyomata. Genes Chromosomes Cancer 2000;28:235-45. (Pubitemid 30399553)
8. Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007;7:899-910. (Pubitemid 350165857)
9. Kazmierczak B, Dal Cin P, Wanschura S, et al. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 1998;23:279-85. (Pubitemid 28507366)
10. Sornberger KS, Weremowicz S, Williams AJ, et al. Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6. Cancer Genet Cytogenet 1999;114:9-16. (Pubitemid 29469685)
11. Ingraham SE, Lynch RA, Kathiresan S, Buckler AJ, Menon AG. hREC2, a RAD51-like gene, is disrupted by t(12;14) (q15;q24.1) in a uterine leiomyoma. Cancer Genet Cytogenet 1999;115:56-61. (Pubitemid 29505220)
12. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005;219:125-35. (Pubitemid 40269475)
13. Ligon AH, Scott IC, Takahara K, Greenspan DS, Morton CC. PCOLCE deletion and expression analyses in uterine leiomyomata. Cancer Genet Cytogenet 2002;137:133-7. (Pubitemid 35266859)
14. Schoenmakers EF, Bunt J, Hermers L, et al. Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma. Genes Chromosomes Cancer 2013;52:11-23.
15. Quintana DG. ORC5L, a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases. J Biol Chem 1998;273:27137-45. (Pubitemid 28500421)
16. Pandis N, Heim S, Willén H, et al. Histologic-cytogenetic correlations in uterine leiomyomas. Int J Gynecol Cancer 1991;1:163-8.
17. Mäkinen N, Mehine M, Tolvanen J, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 2011;334:252-5.
18. Conaway RC, Conaway JW. Function and regulation of the Mediator complex. Curr Opin Genet Dev 2011;21:225-30.
19. Lehtonen HJ. Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 2011;10:397-411.
20. Lehtonen R, Kiuru M, Vanharanta S, et al. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol 2004;164:17-22. (Pubitemid 38364585)
21. Stephens PJ, Greenman CD, Fu B, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011;144:27-40.
22. Kloosterman WP, Tavakoli-Yaraki M, van Roosmalen MJ, et al. Constitutional chromothripsis rearrangements involve clustered double-stranded DNA breaks and nonhomologous repair mechanisms. Cell Rep 2012;1:648-55.
23. Kloosterman WP, Hoogstraat M, Paling O, et al. Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer. Genome Biol 2011;12:R103.
24. Molenaar JJ, Koster J, Zwijnenburg DA, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012;483:589-93.
25. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007;315:1576-9. (Pubitemid 46449474)
26. Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460:705-10.
27. Garcia-Torres R, Cruz D, Orozco L, Heidet L, Gubler MC. Alport syndrome and diffuse leiomyomatosis: clinical aspects, pathology, molecular biology and extracellular matrix studies: a synthesis. Nephrologie 2000;21:9-12. (Pubitemid 30123190)
28. Hodge JC, Kim TM, Dreyfuss JM, et al. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profiling of the t(12;14) and evidence in support of predisposing genetic heterogeneity. Hum Mol Genet 2012;21:2312-29.
29. Vanharanta S, Pollard PJ, Lehtonen HJ, et al. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. Hum Mol Genet 2006;15:97-103. (Pubitemid 43020108)
30. Nilbert M, Heim S, Mandahl N, Floderus UM, Willen H, Mitelman F. Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas. Hum Genet 1990;85:605-11. (Pubitemid 20364312)
31. Nibert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 1990;2:3-13. (Pubitemid 20300429)
32. Forment JV, Kaidi A, Jackson SP. Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat Rev Cancer 2012;12:663-70.
33. Wu C, Wyatt AW, McPherson A, et al. Poly-gene fusion transcripts and chromothripsis in prostate cancer. Genes Chromosomes Cancer 2012;51:1144-53.
34. Rausch T, Jones DT, Zapatka M, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 2012;148:59-71.
35. Northcott PA, Shih DJ, Peacock J, et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 2012;488:49-56.
36. Cuevas EP, Escribano O, Chiloeches A, et al. Role of insulin receptor substrate-4 in IGF-I-stimulated HEPG2 proliferation. J Hepatol 2007;46:1089-98. (Pubitemid 46669737)
37. Jerez A, Sugimoto Y, Makishima H, et al. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood 2012;119:6109-17.
38. McNerney ME, Brown CD, Wang X, et al. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood 2013;121:975-83.
39. Vadnais C, Davoudi S, Afshin M, et al. CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage. Nucleic Acids Res 2012;40:4483-95.
40. Yang Z, Cao Y, Zhu X, Huang Y, Ding Y, Liu X. Znhit1 causes cell cycle arrest and down-regulates CDK6 expression. Biochem Biophys Res Commun 2009;386:146-52.
41. Yu ZK, Gervais JL, Zhang H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc Natl Acad Sci U S A 1998;95:11324-9.
42. Litovkin KV, Ivanova OV, Bauer A, Hoheisel JD, Bubnov VV, Zaporozhan VN. Microarray study of gene expression in uterine leiomyoma. Exp Oncol 2008;30:106-11. (Pubitemid 351951385)
43. Schoenmakers EF, Huysmans C, Van de Ven WJ. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res 1999;59:19-23. (Pubitemid 29062948)